Digital Behavior Change Interventions for the Prevention and Management of Type 2 Diabetes: Systematic Market Analysis
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Background: Advancements in technology offer new opportunities for the prevention and management of type 2 diabetes. Venture capital companies have been investing in digital diabetes companies that offer digital behavior change interventions (DBCIs). However, little is known about the scientific evidence underpinning such interventions or the degree to which these interventions leverage novel technology-driven automated developments such as conversational agents (CAs) or just-in-time adaptive intervention (JITAI) approaches. Objective: Our objectives were to identify the top-funded companies offering DBCIs for type 2 diabetes management and prevention, review the level of scientific evidence underpinning the DBCIs, identify which DBCIs are recognized as evidence-based programs by quality assurance authorities, and examine the degree to which these DBCIs include novel automated approaches such as CAs and JITAI mechanisms. Methods: A systematic search was conducted using 2 venture capital databases (Crunchbase Pro and Pitchbook) to identify the top-funded companies offering interventions for type 2 diabetes prevention and management. Scientific publications relating to the identified DBCIs were identified via PubMed, Google Scholar, and the DBCIs’ websites, and data regarding intervention effectiveness were extracted. The Diabetes Prevention Recognition Program (DPRP) of the Center for Disease Control and Prevention in the United States was used to identify the recognition status. The DBCIs’ publications, websites, and mobile apps were reviewed with regard to the intervention characteristics. Results: The 16 top-funded companies offering DBCIs for type 2 diabetes received a total funding of US $2.4 billion as of June 15, 2021. Only 4 out of the 50 identified publications associated with these DBCIs were fully powered randomized controlled trials (RCTs). Further, 1 of those 4 RCTs showed a significant difference in glycated hemoglobin A1c (HbA1c) outcomes between the intervention and control groups. However, all the studies reported HbA1c improvements ranging from 0.2% to 1.9% over the course of 12 months. In addition, 6 interventions were fully recognized by the DPRP to deliver evidence-based programs, and 2 interventions had a pending recognition status. Health professionals were included in the majority of DBCIs (13/16, 81%,), whereas only 10% (1/10) of accessible apps involved a CA as part of the intervention delivery. Self-reports represented most of the data sources (74/119, 62%) that could be used to tailor JITAIs. Conclusions: Our findings suggest that the level of funding received by companies offering DBCIs for type 2 diabetes prevention and management does not coincide with the level of evidence on the intervention effectiveness. There is considerable variation in the level of evidence underpinning the different DBCIs and an overall need for more rigorous effectiveness trials and transparent reporting by quality assurance authorities. Currently, very few DBCIs use automated approaches such as CAs and JITAIs, limiting the scalability and reach of these solutions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nahum-Shani, I., Smith, S. N., Spring, B. J., Collins, L. M., Witkiewitz, K., Tewari, A., & Murphy, S. A. (2018) · Annals of Behavioral Medicine · doi:10.1007/s12160-016-9830-8 · Cited by 2,171 · cited 3×
“More specifically, JITAIs adapt the provision of intervention content (eg, the type, timing, and intensity) by measuring the health condition or patient behavior with mobile technology such as smartphones, sensors, and software analytics to deliver intervention content at the time and in the context that the person ne…”
BackgroundThe Diabetes Prevention Program (DPP)
The Diabetes Prevention Program (DPP) Research Group (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2165 · Cited by 1,938
Impaired Fasting Glucose and Impaired Glucose Tolerance
Nathan, D. M., Davidson, M. B., DeFronzo, R. A., Heine, R. J., Henry, R. R., Pratley, R., & Zinman, B. (2007) · Diabetes Care · doi:10.2337/dc07-9920 · Cited by 1,396
Conversational agents in healthcare: a systematic review
Laranjo, L., Dunn, A. G., Tong, H. L., Kocaballi, A. B., Chen, J., Bashir, R., Surian, D., Gallego, B., Magrabi, F., Lau, A. Y. S., et al. (2018) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocy072 · Cited by 1,388 · cited 1×
“CAs, also known as chatbots, are computer systems that imitate human conversation using text or spoken language and can offer personalized human-like interactions [15-18].”
BackgroundEstablishing and maintaining long-term human-computer relationships
Bickmore, T. W., & Picard, R. W. (2005) · ACM Transactions on Computer-Human Interaction · doi:10.1145/1067860.1067867 · Cited by 1,333 · cited 1×
“Evidence from interventions using CAs show promising findings in terms of patient satisfaction [19], treatment success [20], and the capability to build work alliances with the patient [21-23].”
BackgroundQuinn, C. C., Shardell, M. D., Terrin, M. L., Barr, E. A., Ballew, S. H., & Gruber-Baldini, A. L. (2011) · Diabetes Care · doi:10.2337/dc11-0366 · Cited by 650
Nahum-Shani, I., Hekler, E. B., & Spruijt-Metz, D. (2015) · Health Psychology · doi:10.1037/hea0000306 · Cited by 568
Conversational Agents in Health Care: Scoping Review and Conceptual Analysis
Tudor Car, L., Dhinagaran, D. A., Kyaw, B. M., Kowatsch, T., Joty, S., Theng, Y.-L., & Atun, R. (2020) · Journal of Medical Internet Research · doi:10.2196/17158 · Cited by 553 · cited 1×
“CAs, also known as chatbots, are computer systems that imitate human conversation using text or spoken language and can offer personalized human-like interactions [15-18].”
BackgroundSelf-citationHou, C., Carter, B., Hewitt, J., Francisa, T., & Mayor, S. (2016) · Diabetes Care · doi:10.2337/dc16-0346 · Cited by 411
Systematic review of smartphone-based passive sensing for health and wellbeing
Cornet, V. P., & Holden, R. J. (2018) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2017.12.008 · Cited by 406 · cited 1×
“Measurements included self-report data or sensor and device analytics [40-42].”
MethodA systematic review of just-in-time adaptive interventions (JITAIs) to promote physical activity
Hardeman, W., Houghton, J., Lane, K., Jones, A., & Naughton, F. (2019) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-019-0792-7 · Cited by 396 · cited 2×
“More specifically, JITAIs adapt the provision of intervention content (eg, the type, timing, and intensity) by measuring the health condition or patient behavior with mobile technology such as smartphones, sensors, and software analytics to deliver intervention content at the time and in the context that the person ne…”
BackgroundFleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020) · Diabetes Care · doi:10.2337/dci19-0062 · Cited by 306
Bonoto, B. C., de Araújo, V. E., Godói, I. P., de Lemos, L. L. P., Godman, B., Bennie, M., Diniz, L. M., & Junior, A. A. G. (2017) · JMIR mhealth and uhealth · doi:10.2196/mhealth.6309 · Cited by 294 · cited 2×
“These reviews generally found DBCIs to be effective in improving diabetes-related outcomes, particularly HbA1c [51,52,61-64], which is in line with our findings; nevertheless, they also concur that the current evidence is limited and there is a need for adequately powered, rigorous trials with long-term follow-ups to…”
BackgroundResultSchachner, T., Keller, R., & v Wangenheim, F. (2020) · Journal of Medical Internet Research · doi:10.2196/20701 · Cited by 267 · cited 1×
“CAs, also known as chatbots, are computer systems that imitate human conversation using text or spoken language and can offer personalized human-like interactions [15-18].”
BackgroundSelf-citationJust-in-the-Moment Adaptive Interventions (JITAI): A Meta-Analytical Review
Wang, L., & Miller, L. C. (2020) · Health Communication · doi:10.1080/10410236.2019.1652388 · Cited by 264
Wu, X., Guo, X., & Zhang, Z. (2019) · JMIR mHealth and uHealth · doi:10.2196/12297 · Cited by 249 · cited 3×
“Our findings are in line with previous studies that reviewed apps for self-management and lifestyle modification in type 2 diabetes patients [51-53] and are also similar to the opinion of clinical experts regarding important intervention components [53,54].”
BackgroundResultJohansen, M. Y., MacDonald, C. S., Hansen, K. B., Karstoft, K., Christensen, R., Pedersen, M., Hansen, L. S., Zacho, M., Wedell-Neergaard, A.-S., Nielsen, S. T., et al. (2017) · JAMA · doi:10.1001/jama.2017.10169 · Cited by 244
Response to a relational agent by hospital patients with depressive symptoms
Bickmore, T. W., Mitchell, S. E., Jack, B. W., Paasche-Orlow, M. K., Pfeifer, L. M., & O’Donnell, J. (2010) · Interacting with Computers · doi:10.1016/j.intcom.2009.12.001 · Cited by 218
Hauser-Ulrich, S., Künzli, H., Meier-Peterhans, D., & Kowatsch, T. (2020) · JMIR mHealth and uHealth · doi:10.2196/15806 · Cited by 210 · cited 1×
“Evidence from interventions using CAs show promising findings in terms of patient satisfaction [19], treatment success [20], and the capability to build work alliances with the patient [21-23].”
BackgroundSelf-citationAdvancing Models and Theories for Digital Behavior Change Interventions
Hekler, E. B., Michie, S., Pavel, M., Rivera, D. E., Collins, L. M., Jimison, H. B., Garnett, C., Parral, S., & Spruijt-Metz, D. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.06.013 · Cited by 174 · cited 1×
“DBCIs are interventions that use digital technology to encourage and support behavior change that will maintain or improve health through the prevention and management of health problems and can, for example, be delivered through computer programs, websites, mobile apps, or wearable devices [12].”
BackgroundRapid evidence review of mobile applications for self-management of diabetes
Veazie, S., Winchell, K., Gilbert, J., Paynter, R., Ivlev, I., Eden, K. B., Nussbaum, K., Weiskopf, N., Guise, J.-M., & Helfand, M. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4410-1 · Cited by 170 · cited 3×
“Our findings are in line with previous studies that reviewed apps for self-management and lifestyle modification in type 2 diabetes patients [51-53] and are also similar to the opinion of clinical experts regarding important intervention components [53,54].”
BackgroundResultBérubé, C., Schachner, T., Keller, R., Fleisch, E., v Wangenheim, F., Barata, F., & Kowatsch, T. (2021) · Journal of Medical Internet Research · doi:10.2196/25933 · Cited by 133 · cited 1×
“CAs, also known as chatbots, are computer systems that imitate human conversation using text or spoken language and can offer personalized human-like interactions [15-18].”
BackgroundSelf-citationThomas, J. G., & Bond, D. S. (2015) · Health Psychology · doi:10.1037/hea0000304 · Cited by 117
Current Issues and Future Directions for Research Into Digital Behavior Change Interventions
Yardley, L., Choudhury, T., Patrick, K., & Michie, S. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.07.019 · Cited by 112
Toro-Ramos, T., Michaelides, A., Anton, M., Karim, Z., Kang-Oh, L., Argyrou, C., Loukaidou, E., Charitou, M. M., Sze, W., & Miller, J. D. (2020) · JMIR mHealth and uHealth · doi:10.2196/17842 · Cited by 107
Kowatsch, T., Schachner, T., Harperink, S., Barata, F., Dittler, U., Xiao, G., Stanger, C., v Wangenheim, F., Fleisch, E., Oswald, H., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/25060 · Cited by 103 · cited 1×
“Evidence from interventions using CAs show promising findings in terms of patient satisfaction [19], treatment success [20], and the capability to build work alliances with the patient [21-23].”
BackgroundSelf-citationAmante, D. J., Harlan, D. M., Lemon, S. C., McManus, D. D., Olaitan, O. O., Pagoto, S. L., Gerber, B. S., & Thompson, M. J. (2021) · JMIR Diabetes · doi:10.2196/25574 · Cited by 44
Virtual Humans in Health-Related Interventions: A Meta-Analysis
Ma, T., Sharifi, H., & Chattopadhyay, D. (2019) · Extended Abstracts of the 2019 CHI Conference on Human Factors in Computing Systems · doi:10.1145/3290607.3312853 · Cited by 37 · cited 1×
“Evidence from interventions using CAs show promising findings in terms of patient satisfaction [19], treatment success [20], and the capability to build work alliances with the patient [21-23].”
Background
Cited by
Tarricone, R., Petracca, F., Svae, L., Cucciniello, M., & Ciani, O. (2024) · eBioMedicine · doi:10.1016/j.ebiom.2024.105091 · Cited by 26
“22 In Germany, the fi rst country where health apps assessment is linked with statutory coverage and reimbursement policies, fi ve diabetes apps are listed as prescribable in the DIGA Directory at the end of the fi rst quarter of 2024.”
BackgroundLee, S.-A., & Park, J.-H. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01827-4 · Cited by 22
Schläpfer, S., Schneider, F., Santhanam, P., Eicher, M., Kowatsch, T., Witt, C. M., & Barth, J. (2024) · JMIR Cancer · doi:10.2196/52386 · Cited by 14
Self-citation
Metadata
- Authors
- Keller, R., Hartmann, S., Teepe, G. W., Lohse, K.-M., Alattas, A., Tudor Car, L., Müller-Riemenschneider, F., von Wangenheim, F., Mair, J. L., & Kowatsch, T.
- Venue
- Journal of Medical Internet Research
- Publisher
- JMIR Publications Inc.
- Published
- 2022-01-07
- Volume
- 24
- Issue
- 1
- Pages
- e33348
- ISSN
- 1438-8871 (ISSN-L)
- OpenAlex
- W3211545573
- Cited by
- 46
- References
- 28
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.